For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

Cagrilintide / Semaglutide Blend

A two-component reference pairing an amylin analogue with semaglutide. Each component needs its own identity and regulatory review before a combined request.

Reference variants

Add Cagrilintide / Semaglutide Blend to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mg (5/5)Vial · confirm physical formCAS Multi-component
    $25.88/vialCloseout estimate Regular $51.75. Subject to confirmation; not a stock promise.
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

The listed format combines cagrilintide and semaglutide in one vial at a stated ratio. A combination does not inherit the status of either component, and semaglutide restrictions still apply to the semaglutide portion.

What the review will ask

Confirm the ratio, salt form of each component and the documentation that will accompany a combined preparation before relying on the line item.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Does a blend avoid semaglutide compounding restrictions?

No. Combining semaglutide with another peptide does not remove the restrictions that apply to semaglutide itself. Review current FDA updates for each component.

Review each ingredient, not a blend name

The cagrilintide restriction still matters when semaglutide is added: FDA says cagrilintide cannot be used in compounding under federal law. Semaglutide approval does not transfer to this combination.

Documentation to request

Ask for the identity and amount of each ingredient separately. Do not infer that an equal-ratio supplier vial matches a clinical-trial formulation.

Regulatory context: FDA: unapproved GLP-1 drugs and ingredient restrictions. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Weight-loss clinic sourcing requirements. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale